Cystic Fibrosis Care From Childhood to Adulthood: How the Move to an Adult Clinic Is Planned

The height chart on the wall has not been updated in years, and it does not need to be. The person reading it is seventeen, taller than the nurse who once weighed her in a plastic scale, and she is here for what her mother keeps calling “the transition talk.” She has known this clinic since before she could speak. Now she is being asked to speak for herself.

That is the quiet drama at the center of cystic fibrosis transition to adult care. It is rarely about a dramatic medical change. The disease is the same; the medicines are largely the same. What shifts is who holds the information, who makes the calls, and who sits in the chair when the doctor asks how things are going.

Families often expect a date. What they get, when it is done well, is a process: a few years of practice, a checklist that keeps coming back, and a handover that feels less like a door closing than a corridor with someone walking beside you.

Why does cystic fibrosis transition to adult care matter so much now?

A generation ago, most cystic fibrosis (CF) clinics were pediatric by default, because that was where the patients were. CF is an inherited condition in which a faulty gene, called CFTR, produces thick, sticky mucus that clogs the lungs and the ducts of the pancreas. According to the National Heart, Lung, and Blood Institute, improvements in airway clearance, nutrition, infection control and, more recently, medicines that target the faulty protein itself have changed what a life with CF can look like. Adults with CF now form a large and growing share of the community.

That success created a new problem. A person who is 25, working, perhaps considering parenthood, and living with a chronic lung condition has needs that a children’s hospital is not built to meet. Adult clinics are organized around fertility, bone health, CF-related diabetes, employment, insurance and independent decision-making. Pediatric clinics are organized around growth, school and parents. Neither is better; they are different tools for different life stages.

Cystic fibrosis transition to adult care, then, is the structured handover between those two tools. The word “transition” is doing deliberate work. “Transfer” describes the moment the medical record moves. “Transition” describes the years of preparation before and the settling-in period after. Guidance from the NHS and from adult CF programs generally treats the two as separate events, and the distinction matters because most of the risk sits in the gap between them: the missed appointment, the unrefilled prescription, the young adult who assumes someone else has booked the follow-up.

There is an opinion worth stating plainly here. The single most important predictor of a smooth transition is not the age at transfer or the fame of the adult center. It is whether the young person knows their own condition well enough to act as their own first line of defense. Everything else in this article serves that goal.

What actually happens when care moves from pediatric to adult CF care?

Strip away the paperwork and pediatric to adult CF care follows a recognizable arc. Early in adolescence, the pediatric team starts spending part of each visit talking to the teenager directly, rather than to the parent. The questions are simple at first: What is the name of the medicine you inhale in the morning? What does your airway clearance routine involve? Which pharmacy do you use?

Over the following visits, the team introduces a readiness tool, often a short questionnaire completed by both the young person and the parent. It is not a test with a pass mark. It is a map of what still needs teaching. Gaps get turned into goals for the next visit: learn how to request a repeat prescription, practice calling the clinic line, keep your own list of medicines on your phone.

As the transfer approaches, most programs arrange some form of overlap. That might be a joint appointment with both the pediatric and adult teams in the room, a visit to the adult clinic while still under pediatric care, or a detailed written summary that travels ahead of the patient. The summary usually covers lung function history, the bacteria that have been grown from sputum over the years, nutritional status, any CF-related diabetes or liver involvement, current medicines, allergies and, crucially, the personal context: what has worked, what has not, what the young person worries about.

Then the transfer itself: the first appointment where the adult team is formally responsible. It tends to be longer than a routine visit. The adult clinicians take their own history, repeat baseline tests such as spirometry (a breathing test that measures how much air you can blow out and how fast) and confirm the medicine list. The pediatric team stays available for questions during a defined handover window. After that, the relationship belongs to the adult clinic.

When does transition usually begin, and who is asked to wait?

Ask three CF teams for the right age to transfer and you may get three answers, all defensible. In the United Kingdom, the NHS describes the move to adult services as typically occurring in the mid to late teens. Many programs in North America transfer between roughly 18 and 21, with preparation starting years earlier, often around age 12 to 14. The spread reflects a principle rather than confusion: readiness, not the calendar, decides.

Transition is usually for young people who are medically stable, who have started to take a hand in their own daily care, and whose family is on board. Stability does not mean perfect health. It means the person is not in the middle of a crisis that would make learning new systems unsafe.

Who is usually asked to wait, or to transfer later than peers? Several situations come up repeatedly in clinical guidance and in the experience of CF teams:

• A recent severe pulmonary exacerbation, which is a flare of lung infection and inflammation needing intensive treatment; teams generally prefer to hand over a stable baseline.
• Active evaluation for lung transplant, where continuity with the team that knows the case is especially valuable.
• A newly diagnosed complication such as CF-related diabetes or significant liver disease, until treatment is settled.
• Significant intellectual disability or a mental health crisis, where extra planning and possibly involvement of a caregiver as long-term decision partner is needed.
• Major life upheaval, such as a family move or bereavement, where adding a new medical team would stretch coping capacity.

The reverse also happens. Some 16-year-olds are functionally independent, request adult services and do well with an earlier move. Others reach 21 still relying heavily on a parent, and the sensible response is not to force the date but to intensify the teaching. The decision always belongs to the young person, the family and the treating team together.

What is a transition readiness assessment in CF, and what does it measure?

The phrase sounds like an exam. In practice, a transition readiness assessment is a structured conversation, usually written down, that asks what the young person can already do on their own and what still needs practice. Most tools used in CF clinics cover a handful of domains, and each maps onto a real-life task that adult clinics will expect the patient to handle.

Knowledge of the condition comes first. Can the young person explain, in their own words, why the lungs make thick mucus and why airway clearance matters? Can they name the bacteria they have grown in the past and why infection control rules exist? This is not academic. An adult who understands why cross-infection precautions matter is far more likely to follow them in a waiting room.

Medication management is the second domain: knowing the names and purposes of medicines, recognizing when a supply is running low, understanding how to request a refill, and knowing what to do if a dose is missed (the answer to that last question always comes from the prescribing team, never from a friend or a search engine).

Navigating the system is third. Booking appointments, arriving with a list of questions, knowing how to contact the clinic between visits, understanding insurance or health-service paperwork, and keeping track of results.

Communication and self-advocacy form the fourth domain. Can the young person spend part of a consultation alone with the clinician? Can they say “I do not understand” or “I have not been doing my treatments” without a parent smoothing it over?

Finally, most tools touch on lifestyle and future planning: alcohol, smoking and vaping (all of which carry particular risk for damaged airways), sexual health and fertility, education and work. The assessment is repeated over several visits. Seeing the scores move is, for many teenagers, the first tangible sign that they are becoming the expert in their own care.

How does a CF transition clinic work?

Some centers run a dedicated CF transition clinic, a bridging service staffed by clinicians from both the pediatric and adult teams. Others achieve the same thing through a series of joint appointments. The format matters less than the function, which is to let the young person meet the adult team while the familiar faces are still in the room.

A typical joint visit runs longer than a standard appointment. The pediatric physician or nurse introduces the patient and summarizes the history aloud, which serves two purposes: the adult clinician hears the story with its nuances, and the young person hears their own medical narrative told as a coherent whole, often for the first time. Many describe this as oddly moving.

The adult clinician then takes over part of the consultation. They may ask questions the pediatric team never raised, about relationships, contraception, alcohol, career plans or living arrangements. This is deliberate. Adult clinics assume autonomy, and the joint visit is a rehearsal for that assumption.

Practical orientation follows. Where is the adult clinic physically? How do you check in? Who answers the phone line? What are the cross-infection rules in the new waiting area? CF centers segregate patients according to the bacteria in their lungs, so learning the new clinic’s system before the first solo visit prevents an anxious mistake on day one.

Where a formal bridging clinic does not exist, the same components can be delivered piecemeal: a pre-transfer tour, a video call with the adult nurse specialist, a written welcome pack. Cleveland Clinic and other centers describe the goal in similar terms: no young adult should walk into their first adult appointment as a stranger to the team or the building.

One caution. A CF transition clinic is a bridge, not a destination. Lingering in the overlap for years can blur accountability, with each team assuming the other has ordered a test. Most programs define the overlap period in advance and stick to it.

What changes in an adult cystic fibrosis clinic?

The medicine is continuous; the culture is not. Walking into an adult cystic fibrosis clinic for the first time, most young people notice the differences before anyone explains them. The table below summarizes the shifts families most often describe.

Area	Pediatric CF clinic	Adult CF clinic
Who the clinician addresses	Often the parent, with the child included	The patient; parents join by invitation
Consent and confidentiality	Parent consents; information shared with family	Patient consents; information shared only with permission
Clinical emphasis	Growth, nutrition, school, infection prevention	Lung function trends, CF-related diabetes, bone density, fertility, work, mental health
Appointment style	Frequent, structured, often with play or distraction support	Scheduled by the patient; missed visits may not be chased as actively
Emergency access	Parent calls; team often knows the family voice	Patient calls; clear instructions on when and how
Screening added	Annual checks focused on growth and lung health	Adds screening for diabetes, liver disease, osteoporosis, and fertility counseling

Two changes deserve emphasis. The first is confidentiality. In most adult systems, the clinician cannot share results with a parent unless the patient agrees. Families sometimes experience this as a wall; it is better understood as a door the young adult now controls, and many choose to keep it wide open.

The second is the widening of the clinical lens. Johns Hopkins and Mayo Clinic both describe adult CF complications that pediatric teams monitor less intensively: CF-related diabetes, which is caused by scarring of the insulin-producing pancreas rather than by lifestyle; reduced bone density from chronic inflammation and malabsorption; and fertility questions, since most men with CF are infertile due to a blocked or absent vas deferens while remaining able to father children with assisted techniques. These topics arrive quickly in adult clinics, and a good transition prepares the young person to hear them.

How do medicines and daily treatments fit into the handover?

Nothing about a person’s prescriptions should change simply because their chart moved buildings. The adult team will review every medicine, but a review is not a rewrite. Any adjustment comes from clinical reasoning shared with the patient, and the decision remains with the prescribing clinician.

What does change is the expectation of ownership. By the time of transfer, the young adult is expected to know each treatment by name and purpose. In broad classes, most daily CF regimens include some combination of the following, described here for understanding rather than as any recommendation:

• Airway clearance techniques, such as breathing exercises, a vibrating vest or handheld devices, which physically loosen mucus so it can be coughed out.
• Inhaled medicines that thin mucus or open airways, delivered by nebulizer (a device that turns liquid into a fine mist).
• Inhaled or oral antibiotics used to suppress chronic bacterial infection or to treat flares.
• Pancreatic enzyme replacement, taken with food so that fat and protein can be absorbed, because the thickened pancreatic ducts block the body’s own enzymes.
• Fat-soluble vitamins, since malabsorption leaves people with CF prone to deficiency.
• CFTR modulator therapies, a class of medicines that help the faulty CFTR protein fold or function more normally; eligibility depends on a person’s specific gene variants and is decided by the CF team.

The handover documentation should list all of these, with the reason for each. Adult teams commonly ask the patient to bring their own list to the first visit and compare it against the record, a small exercise that catches surprising numbers of discrepancies.

Timelines are worth knowing in general terms. Changes to chronic therapies are usually judged over months, using lung function trends, weight and exacerbation frequency, rather than over days. According to the NHLBI, treatment intensity often increases with age as lung damage accumulates, which is another reason the adult team wants a clear baseline early. What the adult team will not do is expect the young person to make these judgments alone; the expectation is that they will report honestly so the team can.

What happens to parents during the transition?

Parents of children with CF have often been, for a decade or more, the most competent members of the care team. They have counted enzymes at birthday parties, recognized the early cough of an exacerbation, and argued with insurers at midnight. Being asked to step back is not a relief for many; it is a loss.

Good transition programs name that loss out loud. The parent’s role does not end; it changes from manager to consultant. Practically, that can mean sitting in the waiting room for the first part of the appointment and joining for the last ten minutes, or being copied into a summary letter with the young adult’s agreement. It rarely means disappearing.

There is an evidence-informed reason to make this shift gradual rather than abrupt. Clinical observation across chronic conditions, summarized in NHS transition guidance, is that young adults whose parents withdraw suddenly tend to drop treatments and miss appointments in the first year, while those whose parents never withdraw at all struggle to build independence. The middle path is scaffolding: the parent does less each year, but is visibly available.

Some concrete steps families find useful:

• Agree in advance which tasks the young person will own this year (for example, ordering nebulizer supplies) and which the parent will keep for now.
• Practice the phone call to the clinic together, then have the teenager make it alone the next time.
• Decide together how results will be shared, and revisit the decision after transfer.
• Give the parent their own outlet, whether a CF parent group or a counselor, since their anxiety is real and should not be the young adult’s to manage.

A final observation from years of watching this happen: the parent who says “I trust you” and then lets a small mistake happen without rescue is often doing the most important teaching of all.

What do the first weeks and months after transfer usually look like?

The transfer appointment is over. The young adult walks out with a new clinic card and, often, a slightly hollow feeling. What comes next is predictable enough to plan for.

In the first few weeks, the practical scaffolding gets tested. Does the pharmacy have the new prescriber’s details? Do the nebulizer supplies still arrive? Did the appointment reminder come to the patient’s phone rather than the parent’s? Small logistical failures are common and rarely dangerous if caught, which is why most adult teams schedule the second visit relatively soon after the first, often within the first few months, so that nothing drifts for long.

The first routine adult visit tends to feel different from the transfer appointment. It is shorter and more businesslike. Spirometry is repeated and compared to the baseline. Sputum is sent for culture, the laboratory test that grows bacteria from a sample so the team knows which organisms are present. Weight and body mass index are recorded, since nutritional status tracks closely with lung health in CF. The clinician may raise annual screening for CF-related diabetes, usually with an oral glucose tolerance test, and bone density scanning if it has not been done.

Emotionally, the pattern many young adults describe is a dip around the second or third month, when the novelty has gone and the absence of the old team is felt. That is normal. It becomes a concern only if it turns into avoidance: canceling appointments, skipping treatments, ignoring the clinic’s calls. Adult teams know this pattern and generally welcome an honest “I am finding this hard” far more than a silent disappearance.

Within the first year, most people have found their footing. They know the nurse’s name, they have used the phone line, and they have had at least one conversation the pediatric clinic would never have started. Cleveland Clinic and other centers describe this first year as the true end of transition, which is one more reason to treat the transfer date as a midpoint rather than a finish line.

How do school, work and mental health fit into the plan?

Transition to adult care usually collides with every other transition of early adulthood: leaving school, starting work or college, moving out, forming relationships. Treating the medical handover in isolation from those changes is a common and costly mistake.

Education and work first. A daily CF regimen can take one to two hours or more, according to descriptions from the NHLBI and CF programs, split between airway clearance, nebulized treatments and enzyme management around meals. A young adult heading to a dormitory or a shift-based job needs a plan for where and when that happens. Adult CF teams routinely write letters supporting reasonable adjustments, such as a private space for nebulizers or flexibility during exacerbations. Asking for these before the first term or first week is easier than after a crisis.

Mental health deserves a plainly stated priority. Depression and anxiety are more common in people with CF and in their caregivers than in the general population, a finding reflected in international CF mental health guidance and echoed by Mayo Clinic’s overview of the condition. Adult CF clinics increasingly screen for both at annual review. Screening is not a judgment; it is a recognition that living with a demanding, lifelong condition takes a toll, and that treating the toll improves the capacity to do the treatments.

Relationships and sexual health come up early in adult clinics, sometimes to the surprise of the young person. Fertility counseling is routine: most men with CF have absent or blocked sperm ducts, and women with CF may have thicker cervical mucus and irregular cycles related to nutrition, though many conceive naturally. Contraception, pregnancy planning and the way pregnancy interacts with lung function are all standard adult-clinic conversations, best had before they are urgent.

Substance use closes the list. Smoking and vaping damage airways that are already compromised, and alcohol interacts with several CF medicines and with liver health. Adult teams ask about these directly and without lecturing. Honesty gets better care.

What people often get wrong about cystic fibrosis transition to adult care

Myths about cystic fibrosis transition to adult care tend to cluster around fear of loss. Here are the ones clinicians hear most often, and what the evidence and experience actually suggest.

“Transfer happens on your eighteenth birthday.” Almost never. Age is one input among several. Readiness, medical stability and life circumstances drive the timing, and programs across the NHS and North America describe ranges rather than fixed dates.

“The adult team will change all my medicines.” Adult clinicians review, they do not routinely overhaul. Any change follows a clinical reason discussed with the patient and rests with the prescriber.

“Adult clinics do not care as much.” Adult clinics care differently. They expect the patient to initiate contact and to report honestly. That can feel like indifference to someone used to being chased. It is, in fact, respect for autonomy, and teams will explain how to reach them.

“My parents will be shut out.” Confidentiality rules shift control to the patient, not away from the family. Most young adults choose to keep parents involved, and clinics accommodate that readily.

“If I am doing well, transition does not matter.” The reverse is closer to true. People who are well are the ones most tempted to skip visits when nobody is checking. Structured transition exists to prevent exactly that drift.

“Lung function always drops after transfer.” Observational studies have reported dips in adherence and clinic attendance around transfer in some cohorts, but this is not inevitable and appears to be reduced by structured preparation. Lung function decline in CF is driven by the disease, not by the building you visit.

“Once transferred, I cannot ask the old team anything.” Most programs define a handover window during which the pediatric team remains reachable. After that, the adult team is the right contact, and they will have the full record.

What does the evidence actually show about transition outcomes?

Honesty requires saying that the evidence base for CF transition is thinner than the volume of guidance might suggest. Most published work consists of single-center descriptions of programs, surveys of young people and parents, and observational comparisons of outcomes before and after a structured process was introduced. Randomized trials are rare, for understandable ethical and practical reasons. Nobody wants to assign a teenager to “no preparation.”

Within those limits, several findings recur. Structured programs, with named coordinators, readiness assessments and joint visits, are associated with fewer gaps between the last pediatric and first adult appointment. Young people who have practiced independent consultations report feeling more confident and more satisfied with the new team. Parents who receive explicit guidance about their changing role report less distress. These are consistent, plausible and useful, but they are associations from mostly uncontrolled studies, not proof of cause.

What the evidence does not clearly show is a measurable protective effect on lung function or exacerbation rates attributable to the transition process itself. Lung function in CF is shaped by genetics, infection history, nutrition, adherence and access to modulator therapy. Disentangling the contribution of a well-run handover from all of that is, so far, beyond the data.

Why, then, do virtually all CF centers invest heavily in transition? Because the downside risks are well documented across chronic conditions: loss to follow-up, lapses in prescriptions and delayed recognition of complications all cluster in the years after leaving pediatric care. Preventing those is worth doing even without a trial proving it improves a breathing test.

A fair summary: the evidence supports structured transition as good practice grounded in consistent observational data and clinical consensus. It does not support promises about outcomes, and any program that makes them is overselling. The best programs describe what they do and why, then measure whether their own patients stay engaged.

Questions to ask your care team before and after the move

The transition process rewards people who arrive with questions. Below are ones that CF nurses and physicians say they wish more families asked, grouped by stage. None of these have universal answers; the point is to hear your own team’s answer.

Before transition begins

• At what age does this program usually start preparation, and what does the first step look like?
• Which readiness tool do you use, and can we see it now so we know what to work toward?
• Who is the named transition coordinator, and how do we reach them?

As transfer approaches

• Will there be a joint appointment or a visit to the adult clinic before transfer?
• What will be in the written summary, and can the patient read it beforehand?
• How long will the pediatric team remain available for questions after the first adult visit?
• What are the cross-infection rules in the adult clinic, and how do they differ from here?
• How will prescriptions and equipment supplies be moved across, and who confirms that it has happened?

At the first adult appointments

• How do I contact the team between visits, and what counts as urgent?
• Which screening tests will you add now, and how often?
• How do you handle information-sharing with my parents if I want them involved?
• Whom do I talk to about mental health, work, fertility or relationships?
• What should I do if I realize I have not been doing my treatments?

For parents

• What can I keep doing that will help rather than hinder?
• Is there support for me as I step back?

Write the answers down. The transition period generates more information than anyone remembers, and a single shared document, kept by the young person, becomes the anchor for the years that follow.

When to call your doctor

The transition period is exactly when a young adult must learn to make the call themselves, so it is worth being specific. The CF team, whether pediatric or adult, wants to hear from you promptly if any of the following occurs. This is general guidance drawn from mainstream sources including the NHS, Mayo Clinic and MedlinePlus; your own team may give you a personalized plan that takes precedence.

Seek urgent or emergency care for:

• Coughing up blood in more than streaks, or any large amount, which can signal bleeding from damaged airway vessels.
• Sudden, sharp chest pain with breathlessness, which can indicate a collapsed lung (pneumothorax), a recognized CF complication.
• Severe breathlessness at rest, blue or gray lips, or confusion.
• Severe abdominal pain with vomiting and inability to pass stool, which can indicate a bowel blockage specific to CF known as distal intestinal obstruction syndrome.
• Thoughts of harming yourself; mental health emergencies are medical emergencies.

Contact the clinic within a day or so for:

• A cough that is worse, more frequent or producing more or darker sputum than usual for several days.
• Fever, fatigue, or reduced exercise tolerance that does not settle.
• Unintended weight loss or loss of appetite.
• Increased thirst, frequent urination or unexplained tiredness, which can be early signs of CF-related diabetes.
• Running out of, or being unable to obtain, any regular medicine or equipment.
• Missing several days of treatments for any reason; the team would rather know than guess.

A practical rule that many adult CF nurses teach: if you are asking yourself whether to call, call. The clinic phone line exists for exactly that uncertainty, and using it early is a mark of good self-management, not weakness.

How can you prepare over the next year?

Transition works best when it is broken into small, ordinary acts of practice rather than one large conversation. What follows is a rough sequence that many CF teams use, adapted to the individual. Treat it as a menu, not a schedule.

In the first few months, focus on knowledge. The young person writes their own one-page summary: diagnosis, gene variants if known, main medicines and why each is taken, bacteria previously grown, allergies, and the names of the team. Keep it on a phone. Update it after every visit.

Next, practice communication. At the following appointment, the teenager spends the first ten minutes alone with the clinician. Parents wait outside. Afterward, everyone debriefs. Repeat until it feels normal.

Then move to logistics. The young person makes one clinic phone call, requests one prescription refill, and orders one batch of equipment, each with a parent nearby but not intervening. Mistakes here are cheap and instructive.

Around the midpoint of the year, revisit the readiness assessment. Compare it with the first version. Set two or three specific goals for the remaining months based on what has not moved.

In the final stretch before transfer, arrange the overlap: a joint appointment, a tour of the adult clinic, a look at the written summary. Confirm in writing how prescriptions and supplies will move. Agree, as a family, how information will be shared afterward.

Throughout, keep the medical routine steady. Transition is not the time to trial a new airway clearance device or renegotiate treatments unless the team suggests it. Stability is the platform on which independence is built.

One last thought for the seventeen-year-old reading the height chart. The clinic that has known you since infancy is not sending you away. It is handing you the file, because you have earned the right to carry it.

Frequently asked questions

What age does cystic fibrosis transition to adult care usually start?

Preparation typically begins in early adolescence, often around 12 to 14, with the actual transfer in the late teens or early twenties depending on readiness. The NHS describes the move to adult services as usually happening in the mid to late teens. Age is one factor among several; medical stability, self-management skills and family circumstances carry equal weight, and the timing is agreed with the CF team rather than set by a birthday.

How is pediatric to adult CF care actually handed over?

Through a written summary, an overlap period and a formal first adult appointment. The pediatric team prepares a detailed record covering lung function history, sputum cultures, nutrition, complications and current medicines. Many programs arrange a joint visit or a tour of the adult clinic beforehand. The first adult appointment is usually longer, repeats baseline tests such as spirometry, and confirms the medicine list. The pediatric team stays reachable for a defined period afterward.

What is a CF transition clinic?

A CF transition clinic is a bridging service where pediatric and adult team members see the young person together before full transfer. Its purpose is to let the patient meet the new team while familiar clinicians are still present, hear their own history summarized, and learn the adult clinic’s practical systems such as check-in and cross-infection rules. Not every center has a formal one; joint appointments or pre-transfer visits serve the same function.

What does a transition readiness assessment in CF measure?

It measures how much of their own care a young person can already manage across several domains: understanding the condition, knowing medicines and how to obtain refills, navigating appointments and phone lines, communicating independently with clinicians, and handling lifestyle topics such as smoking, alcohol and sexual health. The assessment is repeated over several visits so that gaps become teaching goals, and it is used to guide timing rather than to pass or fail anyone.

Will my medicines change when I move to an adult cystic fibrosis clinic?

Not automatically. The adult team reviews every medicine at the first visit and compares the record with the patient’s own list, but a review is not a rewrite. Any change follows a clinical reason discussed with you and rests with the prescribing clinician. Treatment intensity in CF often increases over adult life as lung damage accumulates, which is why the adult team wants a clear baseline early, not because transfer itself triggers changes.

Can my parents still come to appointments after I transfer?

Yes, if you want them there. In most adult systems, confidentiality rules mean the clinician shares information only with the patient’s permission, which puts the decision in your hands rather than excluding your family. Many young adults choose to have a parent join for part of the visit or receive copies of summary letters. Clinics generally accommodate whichever arrangement you and your family agree on, and it can be revisited at any time.

Why do adult CF clinics screen for diabetes and bone health?

Because both become more common with age in CF. CF-related diabetes results from scarring of the insulin-producing pancreas rather than from lifestyle, and Mayo Clinic and Johns Hopkins describe it as a frequent adult complication that is screened for annually, often with an oral glucose tolerance test. Reduced bone density arises from chronic inflammation, malabsorption of vitamin D and calcium, and reduced activity during illness, so periodic bone density scanning is standard adult-clinic practice.

Does lung function usually get worse after moving to adult care?

Not as a consequence of the move itself. Some observational studies have reported dips in adherence and clinic attendance around transfer, which is why structured preparation exists. Lung function decline in CF is driven by the disease, infection history, nutrition, adherence and access to therapies, not by which building you visit. Well-planned transition aims to prevent the gaps in care that can allow problems to go unnoticed during a busy period of life.

What if I am not ready when my clinic suggests transferring?

Say so. Readiness is the whole point, and CF teams would rather delay a few months and intensify teaching than transfer someone who does not yet know their medicines or how to contact the clinic. Situations such as a recent severe exacerbation, a new complication, transplant evaluation or a major life upheaval are common reasons teams themselves suggest waiting. The decision is made jointly by you, your family and the treating team.

How do I know when to call the CF team versus waiting for my next visit?

Call promptly for a cough that is worse or producing more sputum for several days, fever or fatigue that does not settle, unintended weight loss, new thirst or frequent urination, or running out of any regular medicine. Seek emergency care for coughing up more than streaks of blood, sudden chest pain with breathlessness, severe abdominal pain with vomiting, or thoughts of self-harm. If you are debating whether to call, that is usually reason enough to call.

References

• Cystic Fibrosis – National Heart, Lung, and Blood Institute (NIH)
• Cystic fibrosis – NHS
• Cystic Fibrosis – Cleveland Clinic
• Cystic Fibrosis – MedlinePlus

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.